PharmaVoice

JUNE 27, 2025

Despite worried hand-wringing over a potential slowdown in FDA approvals under the new administration, the agency has been giving the go-ahead to drugs at a near record-setting clip. Meanwhile, the decision-making production has come during a major upheaval inside the FDA. Please let us know if you have feedback.

FDA

Pharmacy Times

JULY 12, 2025

One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period. 4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management.

Independent Pharmacies

Pharmacy Times

JULY 19, 2025

A new drug application for lorundrostat is expected to be filed with the FDA in 2025. Am J Prev Med 2017; 53:S172-S181. The most frequent dose limiting adverse effect is hyperkalemia which is dose-related with an incidence of 5% to 7%. mg/d, 1 mg/d, 2 mg/d, and placebo for 12 weeks. 17 The placebo-subtracted reductions in sBP were 8.1

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 23, 2025

J Clin Pharm Ther. 2021;46(5):1254-1262. doi:10.1111/jcpt.13419 13419 Gardenhire DS, Burnett D, Strickland S, Myers TR. A guide to aerosol delivery devices for respiratory therapists. American Association for Respiratory Care. Accessed June 6, 2025. link] Bosnic-Anticevich S, Bakerly ND, Chrystyn H, Hew M, van der Palen J. Patient Prefer Adherence.

Hospitals

Drug Topics

JULY 25, 2025

Between 2017 and 2021, GLP-1 use increased 40-fold, as Indiana University School of Medicine statistics show an estimated 6 million US patients are now on semaglutide (Ozempic) or tirzepatide (Mounjaro). 5 Now, however, researchers are uncovering even further benefits of GLP-1RAs that reach beyond improved cardiometabolic outcomes.

Specialty Pharmacies

Pharmacy Times

JUNE 27, 2025

In the 2017 book The Big Picture , author Sean Carroll seamlessly blends the scientific with the philosophical and comments that “life is not a substance, like water or rock; it’s a process, like fire or a wave crashing on the shore. Potential Roles of the Oncology Pharmacist My friend died of his metastatic cancer in early 2025.

Compounding Pharmacies

Pharmacy Times

JULY 7, 2025

million global deaths recorded in 2017. Updated October 16, 2017. The data, which were published in Nephrology , also highlighted comparable safety among the 2 treatments. The global prevalence is estimated to be about 11% to 13%, with 697.5 million cases of all-stage disease CKD and 1.2 ClinicalTrials.gov identifier: NCT02044653.

Compounding Pharmacies

Drug Topics

JULY 30, 2025

1 Among a total of 533,464 older adults from 2017 to 2020, there were a total of 46,678,010 index and marker medication prescriptions dispensed, with 35,273,662 prescriptions dispensed during the observation period from 2018 to 2020.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 8, 2025

Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed.

HIV Treatment and Prevention Agents

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Drug Topics

JUNE 12, 2025

The FDA approved a label expansion for glecaprevir/pibrentasvir (Mavyret) to treat acute hepatitis C virus (HCV) infection in patients 3 years of age and older with compensated cirrhosis or without cirrhosis, AbbVie announced in a release. 3 READ MORE: Infectious Disease Resource Center Pharmacy practice is always changing.

FDA

Pharmacy Times

JUNE 20, 2025

Updated July 14, 2017. If the bites worsen or signs of infection develop, if symptoms persist beyond a week, or if there are concerns about allergic reactions or fevers, he may need to visit a health care provider. 6 REFERENCES 1. Sun protection factor (SPF). Accessed May 12, 2025. Sunburn: treatment and prevention. Healthchildren.org.

Compounding Pharmacies

Drug Topics

JUNE 16, 2025

Between January 2015 and September 2017, monthly drug overdose deaths increased steadily but plateaued from September 2017 to September 2019. The study authors said that the 12-month moving sum of the drug overdose death rate ranged from 14.54 per 100,000 population in January 2015 to a peak of 33.24 in August 2023.

Specialty Pharmacies

Drug Topics

JUNE 10, 2025

2017 Sep;40(9):1273-1284. Published online June 09, 2025. doi:10.1001/jamainternmed.2025.1580 2025.1580 2. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care. doi: 10.2337/dci17-0026. PMID: 28830958.

Compounding

The Thyroid Pharmacist

AUGUST 1, 2025

Funny enough, in July 2017, on my 35th birthday, I told my husband I was ready to start a family, and went to a naturopathic clinic a few weeks later to get my labs done to prepare for pregnancy, when I realized my period was late! Read more about lab tests for pregnancy in this post.

Health and Personal Care Stores

Drug Topics

JUNE 25, 2025

from 2017 to 2020. Children today are less active than they used to be—and they’re also facing an increased amount of stress.” In recent history, childhood obesity statistics have indeed been alarming, with the US prevalence of youth-related obesity at 19.7%

Compounding

Drug Topics

JULY 11, 2025

2 Not as prominent, urticaria was reported to impact 86 million people in 2017, which was around 1.1% Of the allergic-related skin diseases, AD is one of the most prominent, impacting more than 204 million people globally, or 2.6% of the population. of the population.

Vaccines

The Thyroid Pharmacist

JULY 29, 2025

Her interview followed a series of women who had all experienced symptoms of immune disorders that could be traced back to their implants. There were reports of fatigue, swollen joints, and viral, bacterial, and fungal infections, along with a host of symptoms of immune deficiency appearing in women who had received the saline implants.

Immunization

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Technology

JUNE 16, 2025

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Two patients experienced dose-limiting toxicities and continued to receive the targeted dose.

Labelling

Pharmaceutical Technology

JUNE 12, 2023

In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. CB1 is predominantly found in the central and peripheral nervous system, whereas CB2 is primarily located in immune cells.

Immunization

pharmaphorum

DECEMBER 21, 2020

California-based Gilead announced its strong intentions in oncology in 2017 with its $11.9 Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017. billion buy of Kite Pharma and followed that earlier this year by acquiring immuno-oncology firm Forty Seven for $4.9

Chemotherapy

pharmaphorum

APRIL 30, 2021

The BCMA-targeting CAR-T – also known as cilta-cel – has been filed with the EMA as a treatment for adults with relapsed/refractory multiple myeloma, an incurable form of blood cancer, a few months after it was submitted to the FDA for the same indication. BMS and bluebird had been hoping for a label allowing third-line use.

Immunization

pharmaphorum

JULY 2, 2021

The decision comes after FDA advisors voted six to two in April that Keytruda (pembrolizumab) should not stay on the market as a treatment option for patients with PD-L1-expressing gastric or gastroesophageal junction (GEJ) adenocarcinoma in patients who have received two or more earlier lines of therapy.

FDA

European Pharmaceutical Review

MAY 4, 2023

Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 4 BsMAb amivantamab was designed to enhance adherence of tumour cells to macrophages and natural killer cells, to improve immune-cell mediated killing of cancer cells. 2017; 8(43): 75712–26.

Immunization

The Checkup by Singlecare

NOVEMBER 20, 2023

Steroid sprays All steroid nasal sprays previously required a prescription from your healthcare provider, but some have since received FDA approval for OTC use, such as Flonase (fluticasone propionate), Nasacort (triamcinolone), Nasonex (mometasone), and Rhinocort (budesonide). Others are still available with prescription only.

Mayo Clinic

The FDA Law Blog

NOVEMBER 1, 2023

Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Javitt & Michael D. Shumsky & Philip Won & Adrienne R. Gaulkin & Jeffrey N.

FDA

The Checkup by Singlecare

DECEMBER 12, 2023

Plus, they’re not immune to regular old headaches. Sources 8 non-invasive pain relief techniques that really work , Harvard Health (2017) ACOG response to consensus statement on paracetamol use during pregnancy , American College of Obstetricians and Gynecologists (2021). Harvard Health (2021) Is massage safe during pregnancy?

Immunization

pharmaphorum

JULY 1, 2025

billion, expanding its pipeline with a potential first-in-class treatment for autoimmune diseases as well as adding a novel RNA delivery system to its portfolio. billion, expanding its pipeline with a potential first-in-class treatment for autoimmune diseases as well as adding a novel RNA delivery system to its portfolio.

Pharmaceutical Companies

European Pharmaceutical Review

OCTOBER 19, 2023

Granzyme B is an enzyme released by activated immune cells and using this as a in vivo imaging biomarker has great potential to monitor immune cell activation in a variety of inflammatory diseases, autoimmune diseases, cancer and infections. References Meeting rising demands of a new radiotheranostic era. Internet] Jaafar-Thiel, L.

Chemotherapy

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

The Checkup by Singlecare

OCTOBER 11, 2023

Phenylephrine In September 2023, the FDA announced that a common decongestant found on shelves, phenylephrine, is not actually effective to decrease congestion. Fruits and vegetables are full of vitamins and nutrients (like vitamin C and beta carotene ) that can boost the immune system when you’re sick. Here’s what to skip.

Mayo Clinic

The Checkup by Singlecare

SEPTEMBER 28, 2023

Allergens, he explains, trigger the release of chemicals like histamine from our mast cells (immune cells), leading to congestion and other inflammatory symptoms. Instead of taking vitamin C when you get sick, Dr. Husain says it’s a good idea to take a vitamin C supplement preventively because it boosts the immune system.

Compounding

pharmaphorum

OCTOBER 14, 2021

Lykke Hinsch Gylvin, neuroscience global medical franchise head, Novartis, said: “Antibodies, also known as immunoglobulins, function as part of the healthy immune system, and reduced serum immunoglobulin levels have been previously linked to an apparent increased risk of infection. “We billion in 2019.

Labelling

pharmaphorum

SEPTEMBER 16, 2022

The FDA granted lebrikizumab Fast Track designation in December 2019. As Dr Thyssen further explained, “[i]t all started with the approval of the first biologic in 2017, and has been followed by the approval of other drugs, including one biologic and [three] oral drugs, in the past [one to two] years.

Medical Schools

pharmaphorum

SEPTEMBER 20, 2022

The two companies have been talking to each other since 2017 and formally working together since 2019, when Pfizer started using CytoReason’s biological models in research aimed at developing new drugs for immune-mediated diseases and cancer immunotherapies.

Pharmaceutical Companies

The Checkup by Singlecare

OCTOBER 24, 2023

Food and Drug Administration (FDA). Plus, many fruits are packed with vitamins and antioxidants that will boost your immune system if you’re fighting off a common cold or flu. Try sleeping with your head up on a pillow to reduce the symptoms. Are snot and phlegm our friends?

FDA